Literature DB >> 15234130

Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).

Maureen Maguire1.   

Abstract

OBJECTIVE: To describe characteristics of participants in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) at baseline and to investigate associations among visual function, fundus features, and vision-related quality of life.
DESIGN: Cross-sectional study. PARTICIPANTS: The 1052 participants in CAPT, a multicenter, randomized clinical trial. Eligibility criteria for CAPT included > or =10 large drusen and visual acuity > or =20/40 in each eye.
METHODS: At baseline, the visual acuity, contrast sensitivity, and critical print size for each eye were measured, color stereo photographs of the disc and macula of each eye were taken, and the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) was self-administered. Graders from a central photograph reading center evaluated the photographs for drusen characteristics and focal hyperpigmentation. All procedures were performed using standardized protocols. Associations among characteristics were assessed by Spearman correlation coefficients and multiple linear regression.
RESULTS: Among CAPT participants at baseline, the mean age was 71.0 years, 60.6% were women, and 99.3% were white. The median visual acuity of the better eye was 20/20 and of the worse eye 20/25. In approximately one third of eyes, drusen covered > or =10% of the retina within 3000 microm of the foveal center, and 67.7% of eyes had focal hyperpigmentation. Drusen area and focal hyperpigmentation were weakly correlated (r = -0.08 to -0.18) with the measures of visual function. The measures of visual function were weakly associated with the NEI-VFQ-25 scores. An association of fundus features with NEI-VFQ-25 scores was not found.
CONCLUSION: At baseline, CAPT participants had good visual function and several risk factors for progression to neovascular age-related macular degeneration. Scores on the NEI-VFQ-25 indicated that participants perceived some problems with their vision. Within this relatively homogeneous group of participants, measures of visual function were only weakly associated with the measures of vision-related quality of life.

Entities:  

Mesh:

Year:  2004        PMID: 15234130     DOI: 10.1016/j.ophtha.2003.10.031

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

Review 1.  Age related macular degeneration.

Authors:  Jennifer J Arnold; Wilson Heriot
Journal:  BMJ Clin Evid       Date:  2007-04-01

Review 2.  Laser photocoagulation as treatment of non-exudative age-related macular degeneration: state-of-the-art and future perspectives.

Authors:  Giuseppe Querques; Maria Vittoria Cicinelli; Alessandro Rabiolo; Luigi de Vitis; Riccardo Sacconi; Lea Querques; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-25       Impact factor: 3.117

3.  Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy.

Authors:  Flavio E Hirai; James M Tielsch; Barbara E K Klein; Ronald Klein
Journal:  Ophthalmology       Date:  2010-09-29       Impact factor: 12.079

4.  Specular microscopy ancillary study methods for donor endothelial cell density determination of Cornea Donor Study images.

Authors:  Beth Ann Benetz; Robin L Gal; Katrina J Ruedy; Carmella Rice; Roy W Beck; Andrea D Kalajian; Jonathan H Lass
Journal:  Curr Eye Res       Date:  2006-04       Impact factor: 2.424

5.  Early age-related macular degeneration impairs tolerance to stimulus degradation.

Authors:  Lei Liu; Janis White
Journal:  Optom Vis Sci       Date:  2010-08       Impact factor: 1.973

6.  Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.

Authors:  Gui-Shuang Ying; Maureen G Maguire; Chengcheng Liu; Andrew N Antoszyk
Journal:  Ophthalmology       Date:  2008-07-31       Impact factor: 12.079

7.  The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.

Authors:  Traci E Clemons; Mark C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Maria Figueroa; Molly W Harrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-27       Impact factor: 4.799

8.  Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools.

Authors:  Robert P Finger; Monika Fleckenstein; Frank G Holz; Hendrik P N Scholl
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

9.  Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.

Authors:  Maureen G Maguire; Gui-shuang Ying; Colin A McCannel; Chengcheng Liu; Yang Dai
Journal:  Ophthalmology       Date:  2009-10-22       Impact factor: 12.079

10.  The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration.

Authors:  Keith Evans; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Clin Ophthalmol       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.